Lubomir Sokol
- Pathology and Forensic Medicine top 0.5%
- Oncology top 1%
- Genetics top 0.5%
- Immunology top 2%
- Hematology top 0.5%
- Co-authors
- Samir DaliaThomas P. LoughranAlan F. ListLauren Pinter‐BrownJulio C. ChávezBarbara ProFrancine M. FossElizabeth M. Sagatys
- Topics
- Lymphoma Diagnosis and Treatment (131 papers)Chronic Lymphocytic Leukemia Research (66 papers)Cutaneous lymphoproliferative disorders research (54 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical InvestigationJournal of Clinical Oncology
- Partner nations
- United StatesFranceSpain
In The Last Decade
Lubomir Sokol
250 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Pathology and Forensic Medicine 2.0k
- Oncology 1.8k
- Genetics 1.4k
- Immunology 1.4k
- Hematology 1.3k
Countries citing papers authored by Lubomir Sokol
This map shows the geographic impact of Lubomir Sokol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lubomir Sokol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lubomir Sokol more than expected).
Fields of papers citing papers by Lubomir Sokol
This network shows the impact of papers produced by Lubomir Sokol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lubomir Sokol. The network helps show where Lubomir Sokol may publish in the future.
Co-authorship network of co-authors of Lubomir Sokol
This figure shows the co-authorship network connecting the top 25 collaborators of Lubomir Sokol. A scholar is included among the top collaborators of Lubomir Sokol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lubomir Sokol. Lubomir Sokol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 5 | |
| 5 | 12 | |
| 6 | 4 | |
| 7 | 3 | |
| 8 | 0 | |
| 9 | 4 | |
| 10 | 3 | |
| 11 | 6 | |
| 12 | 24 | |
| 13 | 9 | |
| 14 | 12 | |
| 15 | 2 | |
| 16 | 166 | |
| 17 | 18 | |
| 18 | Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapybreakdown → | 485 |
| 19 | 3 | |
| 20 | 20 |
About Lubomir Sokol
Lubomir Sokol is a scholar working on Genetics, Pathology and Forensic Medicine and Dermatology, having authored 269 papers that have together received 5.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (131 papers), Chronic Lymphocytic Leukemia Research (66 papers) and Cutaneous lymphoproliferative disorders research (54 papers). The work is most often cited by research in Genetics (1.4k citations), Hematology (1.3k citations) and Pathology and Forensic Medicine (2.0k citations). Lubomir Sokol has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Samir Dalia, Thomas P. Loughran, Alan F. List, Lauren Pinter‐Brown, Julio C. Chávez, Barbara Pro, Francine M. Foss, Elizabeth M. Sagatys, Bertrand Coiffier and Sarah McCue Horwitz. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.